Tuesday, November 5, 2024
HomeTagsHoth Therapeutics

Hoth Therapeutics

Hoth Therapeutics Announces HT-ALZ Therapeutic Shows Cognitive Improvements in Alzheimer’s Disease

Hoth Therapeutics, Inc., a patient-focused biopharmaceutical company, announced proof-of-concept data generated using cognitive and behavioral assessments in an Alzheimer's disease mouse model (aged APP/PS1+/-...

Hoth Therapeutics Announces HREC Approval in Australia for the Next Phase of its Trial of BioLexa for Patients with Atopic Dermatitis

Hoth Therapeutics, Inc., a patient-focused biopharmaceutical company, announced it has received approval by the Bellberry Human Research Ethics Committee (HREC) in Australia to initiate...

Hoth Therapeutics Announces HT-ALZ Therapeutic Shows Positive Results – Reduce Amyloid β in Alzheimer’s Disease

Hoth Therapeutics, Inc., a patient-focused biopharmaceutical company, announced proof-of-concept data generated using an Alzheimer's disease mouse model, supporting the therapeutic potential of HT-ALZ. The...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics